Switzerland· 68265001
Ngenla 24 mg/ 1.2 ml, Injektionslösung im Fertigpen
A somatrogon product containing somatrogonum, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Somatrogon is registered in 14 of 19 countries.
Countries holding a registration under ATC H01AC08 (somatrogon), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Somatrogon · ATC H01AC08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of somatrogon costs, country by country.
Normalised to the WHO defined daily dose (2.4 mg), so markets compare like for like.
- Switzerland: $38.71 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Somatrogon · price per daily dose (2.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$38.71
The record
At a glance
Swissmedic (Switzerland)- Active substance
- somatrogonum
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- H01AC08
- ATC class
- Somatrogon
- Defined daily dose
- 2.4 mg, P
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680682650019Fertpen 1 StkCHF 325.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Somatrogon in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNgenlaPfizer Laboratories Div Pfizer Inc
- CanadaNGENLAPFIZER CANADA ULC
- CzechiaNGENLAPfizer Europe MA EEIG, Bruxelles
- SpainNGENLA 24 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAPfizer Europe Ma Eeig
- FinlandNgenlaPfizer Europe MA EEIG
- FranceNGENLA 24 mg, solution injectable en stylo prérempliPFIZER EUROPE MA EEIG (BELGIQUE)
- United KingdomNgenla 24mg/1.2ml solution for injection pre-filled pensPfizer Ltd
- BelgiumNgenla 24 mgPfizer Europe MA
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ngenla
- Liechtenstein · Ngenla
- Norway · Ngenla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/155199fd-b32d-4a60-a551-5097aba46c19 GET /v1/drugs/155199fd-b32d-4a60-a551-5097aba46c19?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "somatrogonum 24 mg",
"valid_from": "2022-11-01",
"limitations": "[{\"description\":\"Anwendung bei Wachstumsstörungen bei nachgewiesenem Somatropin-Mangel bei Kindern und Jugendlichen ab 3 Jahren.<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-11-01\"}]",
"galenic_form": "Inj Lös 24 mg/1.2ml",
"therapeutic_area": null,
"sl_inclusion_date": "2022-11-01",
"self_retention_pct": 10
}See everything about somatrogon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.